CD8A and neoplasm: For instance, oral administration of Bifidobacterium combined with anti-PD-1 antibody can specifically enhance T-cell responses and dendritic cell (DC) functions, thereby promoting CD8+ T-cell priming and accumulation in the tumor microenvironment and preventing melanoma progression [113].